2023 Non-Animal Alternatives Testing Market Report: Market Size, Growth Drivers And Key Trends

As per The Business Research Company's Non-Animal Alternatives Testing Opportunities And Strategies Market Report 2023, The global non-animal alternatives testing market reached a value of nearly $1,569.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 6.0% since 2015. The global non-animal alternatives testing market size is expected to grow from $1,569.4 million in 2020 to $2,315.5 million in 2025 at a rate of 8.1%. The global non-animal alternatives testing market size is then expected to grow at a CAGR of 11.9% from 2025 and reach $4,069.1 million in 2030.

Alternative animal testing technologies are increasingly adopted by the end-use industries due to the pressure from animal rights organizations such as PETA (People for the Ethical Treatment of Animals), and Cruelty-Free International to treat animals ethically. These animal rights' organizations are protesting and conducting media campaigns to stop animal physiological distress and suffering use to testing for research on drugs, cosmetic products, chemicals, and food ingredients. These organizations are working closely with government agencies, educational institutions, and end-use industries to provide funding for developing alternative technologies. Therefore, ethical concerns on animal experiments are creating new legislation in various countries thereby driving the alternative technologies market.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-market

OOCs (organs-on-chips) tool for testing is a major trend in the non-animal alternatives testing market. Organs-on-a-chips (OOCs) are miniature tissues and organs grown in-vitro that enable the modeling of human physiology and disease. OOCs are now being explored worldwide as tools for developing disease models and accurately predicting drug efficacies and toxicities. The advantages of OOCs over cell culture, animal models, and human clinical trials have captured the attention of both the medical and pharmaceutical communities focusing on developing targeted therapies. For instance, in April 2020, researchers at the Massachusetts Institute of Technology (MIT) in the US, developed a new model for Organs-on-a-Chip to develop treatments for inflammatory diseases and afflictions. Organs-on-a-chip consists of millions of cells formed on a platform to replicate the functions of different organs and can be used as an instrument in analyzing and creating new treatments for complex diseases without the use of animals for testing.

The top opportunities in the non-animal alternatives testing market segmented by technology will arise in Cell Culture Technology segment, which will gain $392.1 million of global annual sales by 2025. The top opportunities in the non-animal alternatives testing market segmented by method will arise in Cellular Assay segment, which will gain $309.6 million of global annual sales by 2025. The top opportunities in the non-animal alternatives testing market segmented by end user will arise in Pharmaceutical Industry segment, which will gain $315.3 million of global annual sales by 2025. The non-animal alternatives testing market size will gain the most in the USA at $260.8 million.

Non-Animal Alternatives Testing Market Segmentation:
The non-animal alternatives testing market is segmented by type, by component, by function and by type of traders.
By Technology -
The non-animal alternatives testing market is segmented by technology into:
a) Cell Culture Technology
b) High Throughput Technology
c) Molecular Imaging
d) Omics Technology
e) Other Technologies

By Method -
The non-animal alternatives testing market is segmented by method into:
a) Cellular Assay
b) Biochemical Assay
c) In Silico
d) Ex-Vivo

By End-Users -
The non-animal alternatives testing market is segmented by end-users into:
a) Pharmaceutical Industry
b) Cosmetics And Household Products
c) Diagnostics
d) Chemicals Industry
e) Food & Beverage Industry
f) Other End Users

Major players in the non-animal alternatives testing market include Cyprotex, Bio-Rad Laboratories, Inc., MatTek Corporation, Emulate, Inc, BioIVT.

The regions covered in the global non-animal alternatives testing market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=6215&type=smp

The latest report from The Business Research Company, 'Global Non-Animal Alternatives Testing Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Non-Animal Alternatives Testing Market Report Table Of Content
1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
……
20. Non-Animal Alternatives Testing Market Competitive Landscape
21. Key Mergers And Acquisitions In The Non-Animal Alternatives Testing Market
22. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis
23. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6215

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.